The innate immune mediator group IIA secreted phospholipase A2 modulates lipid droplet formation in prostate cancer cells
Frontiers in Cell and Developmental Biology · 18.05.2026 · 14
DOI: 10.3389/fcell.2026.1774027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 18.05.2026. Verfasst von Monavvar Andarva und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Faculty of Health, Western Sydney University, Campbelltown, NSW, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
We and others have shown that elevated human Group IIA secreted phospholipase A 2 (hGIIA) has both catalysis-dependent and -independent functions that are associated with both acute and chronic inflammatory disorders including cancer. Our novel inhibitors that selectively block hGIIA’s catalysis-independent function slow tumor growth in animal models via interaction with vimentin. The mechanism of this interaction and its consequences for cancer aggressiveness remains unexplored.
Methods
We have used established patient-derived androgen-independent prostate cancer (PCa) cell lines, DU145, PC-3 and vimentin-knockout DU145 (DU145 vim− ) cells treated with hGIIA protein in the presence and absence of our cyclic peptide inhibitor Kesonotide (also known as c2). As lipid metabolism is known to be regulated by vimentin, we examined whether this aspect of vimentin biology was influenced by interaction with hGIIA, focusing on lipid droplet (LD) formation, LD-associated perilipin proteins (PLIN2 and PLIN3) and lipid biosynthetic enzymes (DGAT and FASN). To do this we used the combination of single cell quantitative immunofluorescence and Western blot analysis.
Results
We found that addition of exogenous hGIIA increased LD metabolism as evidenced by LD immunofluorescence signal and this increase is dependent on vimentin in PCa. The response is dependent on hGIIA levels with high concentrations of hGIIA associated with PLIN2 loss, PLIN3 suppression, and DGAT1 induction without FASN upregulation. Kesonotide alone was largely inert. However, at high concentration of hGIIA, Kesonotide attenuated lipid metabolism by neutralizing perilipin remodelling and attenuating DGAT1 induction in knockout cells.
Discussion
Taken together, these findings identify a context-dependent hGIIA LD-remodelling program that is shaped by vimentin, implicating for the first time the hGIIA–vimentin axis in inflammatory cue–driven lipid metabolic rewiring in aggressive PCa.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Faculty of Health, Western Sydney University, Campbelltown, NSW, Australia.
- Medical Oncology Unit, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia.
- Nepean Hospital Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood, NSW, Australia.
- School of Biomedical Sciences, UNSW, Kensington, NSW, Australia.
- Graduate School of Biomedical Engineering, UNSW, Kensington, NSW, Australia.
Zitieren
APA
Andarva, M., Elias, M. G., Sajinovic, M., Mann, T. J., Zhou, J. M., Mellick, A. S., Roberts, T. L., de Souza, P., & Scott, K. F. (2026). The innate immune mediator group IIA secreted phospholipase A2 modulates lipid droplet formation in prostate cancer cells. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1774027
Vancouver
Andarva M, Elias MG, Sajinovic M, Mann TJ, Zhou JM, Mellick AS, et al. The innate immune mediator group IIA secreted phospholipase A2 modulates lipid droplet formation in prostate cancer cells. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1774027
BibTeX
@article{Andarva2026,
author = {Andarva, Monavvar and Elias, Maria George and Sajinovic, Mila and Mann, Timothy J and Zhou, Jasmine M and Mellick, Albert S and Roberts, Tara Laurine and de Souza, Paul and Scott, Kieran F},
title = {The innate immune mediator group IIA secreted phospholipase A2 modulates lipid droplet formation in prostate cancer cells},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1774027}
}
EUVIMED